H19 silencing has been shown to enhance TMZ cytotoxicity in glioma cells through inhibiting epithelial-mesenchymal transition (EMT) via the Wnt/β-catenin pathway (11) and inactivating NF-kB signaling (23). The gene discussed is NFKB1; the disease is central nervous system cancer.